KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock?

Core Viewpoint - KORU Medical Systems, Inc. (KRMD) experienced a significant stock price increase of 5.6% due to positive investor sentiment following FDA clearance for its FreedomEDGE infusion system, which enhances the delivery of large-volume subcutaneous drugs [1][2]. Financial Performance - The company is projected to report a quarterly loss of $0.02 per share, reflecting a year-over-year improvement of 33.3%. Expected revenues are $10.89 million, representing a 23.2% increase from the same quarter last year [3]. - The consensus EPS estimate for KORU Medical Systems has remained stable over the past 30 days, indicating no recent revisions in earnings estimates, which typically correlate with stock price movements [4]. Industry Context - KORU Medical Systems is part of the Zacks Medical Info Systems industry, where Claritev Corporation (CTEV) also operates. CTEV's stock closed 2.3% higher but has seen a decline of 19.9% over the past month [4].